Baxter International
This Deerfield, Ill. company makes devices and other products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.
Courtesy of Baxter International
Company Information
As of 5/23/2022
Country
U.S.
Headquarters
Deerfield, Ill.
Industry
Medical Products and Equipment
CEO
José E. Almeida
Website
Company Type
Public
Ticker
BAX
Revenues ($M)
$12,784
Profits ($M)
$1,284
Market Value ($M)
$39,017.9
Employees
60,000
Acquired Hill-Rom Holdings (2021 rank: 827), Dec. 13, 2021. Market value as of March 31, 2022.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$12,784
9.5%
Profits ($M)
$1,284
16.5%
Assets ($M)
$33,521
-
Total Stockholder Equity ($M)
$9,077
-
Profit Ratios
Profit as % of Revenues
10%
Profits as % of Assets
3.8%
Profits as % of Stockholder Equity
14.1%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
253
EPS % Change (from 2020)
18.8%
EPS % Change (5 year annual rate)
-22.4%
EPS % Change (10 year annual rate)
-4.2%
Total Return
Total Return to Investors (2021)
8.4%
Total Return to Investors (5 year, annualized)
15.4%
Total Return to Investors (10 year, annualized)
14.2%
Lists ranking Baxter International
Latest news for Baxter International
- Health
Shareholder Value and Smart Acquisitions Are Priorities for This Health Care CEOJanuary 4, 2018, 5:13 PM UTC
- Top CEOs on how COVID exposed flaws in supply chain management;3:49News;
- FORTUNE PREMIUMInsights: The Measures Being Implemented By Baxter International For A Healthy Reopening;1:59Collections;
- Balancing act in telehealth;2:22Conferences, Brainstorm Health;
- FORTUNE PREMIUMBaxter International CEO on reopening and leadership during social unrest;8:31Series, On Leading;